Takeda Pharma signs research pact with Samyang
As per the agreement, both the companies will jointly work and organize research for the discovery of DDS technology for RNAi therapeutics based on Samyang’s technology in three
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.